Skip to main content
Fig. 3 | Clinical and Translational Allergy

Fig. 3

From: Clinically relevant effect of rupatadine 20 mg and 10 mg in seasonal allergic rhinitis: a pooled responder analysis

Fig. 3

Time to achieve 50% and 75% response after treatment with rupatadine 10 mg or 20 mg for T4NSS, T2OSS, and T6SS. a Proportion of responders over time to achieve the 50% response in T4NSS. c Proportion of responders over time to achieve 75% response in T4NSS. b Time (days) to achieve the 50% response (T4NSS, T2OSS, and T6SS). d Time (days) to achieve the 75% response (T4NSS, T2OSS, and T6SS). T4NSS Total 4 Nasal Symptom Score, T2OSS Total 2 Ocular Symptom Score, T6SS Total 6 Symptom Score

Back to article page

Clinical and Translational Allergy

ISSN: 2045-7022

Contact us